Roman DBDR Acquisition Corp. II, a special purpose acquisition company with a current market capitalization of $265.6 million, announced the successful completion of its initial public offering (IPO) on December 16, 2024, raising $200 million.
Based in Boca Raton, Florida, the company offered 20 million units at $10 each, with each unit comprising one Class A ordinary share and one-half of one redeemable warrant. The warrants are exercisable for one Class A ordinary share at a price of $11.50 per share.
In conjunction with the IPO, Roman DBDR Acquisition Corp. II also conducted a private placement of 7,385,000 warrants, generating additional gross proceeds of $7,385,000. The private placement included 4,885,000 warrants purchased by the company's sponsor, Roman DBDR Acquisition Sponsor II LLC, and 2,500,000 warrants bought by B. Riley Securities, Inc., the representative of the underwriters for the IPO.
The funds from both the IPO and the private placement, totaling $201,000,000, have been placed into a trust account with Continental Stock Transfer & Trust Company. These funds are intended to support the company's future business transactions, which may include mergers, capital stock exchanges, asset acquisitions, stock purchases, reorganizations, or similar business combinations.
The units began trading on The Nasdaq Stock Market LLC under the ticker symbol DRDBU, with the Class A ordinary shares and warrants separately listed under the symbols DRDB and DRDBW, respectively. According to InvestingPro data, the stock currently trades at $9.97, near its 52-week high, with an average daily trading volume of 1.58 million units. InvestingPro analysis indicates the stock generally trades with low price volatility.
This financial move by Roman DBDR Acquisition Corp. II reflects the company's strategic efforts to secure capital for its operational goals. The company's balance sheet as of December 16, 2024, audited to account for the proceeds from the IPO and the private placement, is included as Exhibit 99.1 in the recent SEC filing. InvestingPro rates the company's overall financial health as FAIR, with additional insights available to subscribers.
The information for this article is based on a press release statement.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.